Back to results
US 12,006,322 B2Granted
Substituted pyridines as PARP1 inhibitors
AssigneeXin Thera, Inc.
InventorsRobert L. Hoffman, Porino Jinjo Va, Joseph Robert Pinchman, Qing Dong, Stephen W. Kaldor
Life of this patent
Estimating the term…
Abstract
Described herein are tricyclic PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer and are of Formula (Ip):
Claims4
A compound:
- or a pharmaceutically acceptable salt or tautomer thereof.
A compound:
Dependencies are inferred from the claim text.